IceCure Medical, Ltd. - ICCM Company Cumulative Debt

IceCure Medical Ltd generates revenue through the sale of ProSense systems for the bloodless removal of neoplasms. High patent barriers and lengthy equipment certification provide significant business protection, as confirmed by the GURU.Markets terminal via its chart of aggregate loans and credits. The value of 0.00 reflects the current debt level while management focuses on expanding distribution and securing new regulatory approvals.

To assess the credit quality of IceCure Medical Ltd (ICCM), the analyst examines the aggregate volume of short-term and long-term loans that determine the issuer's financial stability. By analyzing the total liabilities trend on GURU.Markets, the investor observes the balance between debt load and the expansion of cryoablation systems across US and European markets, where scaling the equipment base requires strict control over the cost of borrowed capital.